METABOLIC SOLUTIONS DEVELOPMENT
Metabolic Solutions Development Company is an emerging biopharmaceutical company developing first in class oral therapeutics to treat diseases associated with metabolic dysfunction, including NASH, polycystic kidney disease, and diabetes, as well as neurodegenerative diseases such as Alzheimer's and Parkinson's disease.
METABOLIC SOLUTIONS DEVELOPMENT
Industry:
Biopharma Biotechnology Life Science
Founded:
2006-01-01
Address:
Kalamazoo, Michigan, United States
Country:
United States
Website Url:
http://www.msdrx.com
Total Employee:
11+
Status:
Active
Contact:
2693436742
Total Funding:
58.52 M USD
Technology used in webpage:
Pound Sterling Japanese Yen AppRiver
Similar Organizations
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - Metabolic Solutions Development
Hopen Life Science Ventures
Hopen Life Science Ventures investment in Series D - Metabolic Solutions Development
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - Metabolic Solutions Development
Hopen Life Science Ventures
Hopen Life Science Ventures investment in Series B - Metabolic Solutions Development
Official Site Inspections
http://www.msdrx.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
